334 related articles for article (PubMed ID: 24638982)
21. MORC2 Enhances Tumor Growth by Promoting Angiogenesis and Tumor-Associated Macrophage Recruitment via Wnt/β-Catenin in Lung Cancer.
Liu M; Sun X; Shi S
Cell Physiol Biochem; 2018; 51(4):1679-1694. PubMed ID: 30504718
[TBL] [Abstract][Full Text] [Related]
22. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
[TBL] [Abstract][Full Text] [Related]
23. The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression.
Ahn R; Sabourin V; Ha JR; Cory S; Maric G; Im YK; Hardy WR; Zhao H; Park M; Hallett M; Siegel PM; Pawson T; Ursini-Siegel J
Cancer Res; 2013 Jul; 73(14):4521-32. PubMed ID: 23695548
[TBL] [Abstract][Full Text] [Related]
24. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
[TBL] [Abstract][Full Text] [Related]
25. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.
Banerjee A; Wu ZS; Qian PX; Kang J; Liu DX; Zhu T; Lobie PE
PLoS One; 2012; 7(11):e50098. PubMed ID: 23185544
[TBL] [Abstract][Full Text] [Related]
26. MTDH in macrophages promotes the vasculogenic mimicry via VEGFA-165/Flt-1 signaling pathway in head and neck squamous cell carcinoma.
Liu X; Lv Z; Zhou S; Kan S; Liu X; Jing P; Xu W
Int Immunopharmacol; 2021 Jul; 96():107776. PubMed ID: 34162144
[TBL] [Abstract][Full Text] [Related]
27. NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription.
Qin L; Xu Y; Xu Y; Ma G; Liao L; Wu Y; Li Y; Wang X; Wang X; Jiang J; Wang J; Xu J
Oncotarget; 2015 Sep; 6(27):23890-904. PubMed ID: 26287601
[TBL] [Abstract][Full Text] [Related]
28. CTEN Inhibits Tumor Angiogenesis and Growth by Targeting VEGFA Through Down-Regulation of β-Catenin in Breast Cancer.
Lu X; Zhou B; Cao M; Shao Q; Pan Y; Zhao T
Technol Cancer Res Treat; 2021; 20():15330338211045506. PubMed ID: 34817293
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages.
Lin EY; Li JF; Bricard G; Wang W; Deng Y; Sellers R; Porcelli SA; Pollard JW
Mol Oncol; 2007 Dec; 1(3):288-302. PubMed ID: 18509509
[TBL] [Abstract][Full Text] [Related]
30. Lipocalin 2 from macrophages stimulated by tumor cell-derived sphingosine 1-phosphate promotes lymphangiogenesis and tumor metastasis.
Jung M; Ören B; Mora J; Mertens C; Dziumbla S; Popp R; Weigert A; Grossmann N; Fleming I; Brüne B
Sci Signal; 2016 Jun; 9(434):ra64. PubMed ID: 27353364
[TBL] [Abstract][Full Text] [Related]
31. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas.
Schroeder JA; Adriance MC; McConnell EJ; Thompson MC; Pockaj B; Gendler SJ
J Biol Chem; 2002 Jun; 277(25):22692-8. PubMed ID: 11950845
[TBL] [Abstract][Full Text] [Related]
32. Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway.
Cohen ED; Ihida-Stansbury K; Lu MM; Panettieri RA; Jones PL; Morrisey EE
J Clin Invest; 2009 Sep; 119(9):2538-49. PubMed ID: 19690384
[TBL] [Abstract][Full Text] [Related]
33. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
34. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
35. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
[TBL] [Abstract][Full Text] [Related]
36. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.
Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390
[TBL] [Abstract][Full Text] [Related]
37. Mouse Breast Carcinoma Monocytic/Macrophagic Myeloid-Derived Suppressor Cell Infiltration as a Consequence of Endothelial Dysfunction in
He Q; Jamalpour M; Bergquist E; Anderson RL; Gustafsson K; Welsh M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768912
[TBL] [Abstract][Full Text] [Related]
38. Wnt5a as an effector of TGFβ in mammary development and cancer.
Serra R; Easter SL; Jiang W; Baxley SE
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):157-67. PubMed ID: 21416313
[TBL] [Abstract][Full Text] [Related]
39. miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b.
Liu Q; Wang Z; Zhou X; Tang M; Tan W; Sun T; Deng Y
Cell Cycle; 2019 Dec; 18(23):3325-3336. PubMed ID: 31601147
[TBL] [Abstract][Full Text] [Related]
40. Wnt signaling in triple negative breast cancer is associated with metastasis.
Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
